The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Pliant Therapeutics Inc (NASDAQ: PLRX) closed at $12.85 down -6.68% from its previous closing price of $13.77. In other words, the price has decreased by -$6.68 from its previous closing price. On the day, 1.2 million shares were traded. PLRX stock price reached its highest trading level at $14.04 during the session, while it also had its lowest trading level at $12.76.
Ratios:
For a deeper understanding of Pliant Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.26 and its Current Ratio is at 10.26. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.17.
On December 08, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $41.
On May 18, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $48.Canaccord Genuity initiated its Buy rating on May 18, 2023, with a $48 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 10 ’24 when Lefebvre Eric sold 12,319 shares for $11.56 per share. The transaction valued at 142,408 led to the insider holds 213,052 shares of the business.
Hull Hans sold 9,900 shares of PLRX for $114,444 on Jul 10 ’24. The Chief Business Officer now owns 227,494 shares after completing the transaction at $11.56 per share. On Jul 10 ’24, another insider, Cummings Keith Lamont, who serves as the Chief Financial Officer of the company, sold 10,911 shares for $11.56 each. As a result, the insider received 126,131 and left with 282,115 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PLRX now has a Market Capitalization of 837954944 and an Enterprise Value of 437669056.
Stock Price History:
Over the past 52 weeks, PLRX has reached a high of $19.62, while it has fallen to a 52-week low of $10.22. The 50-Day Moving Average of the stock is -1.80%, while the 200-Day Moving Average is calculated to be -4.66%.
Shares Statistics:
For the past three months, PLRX has traded an average of 366.38K shares per day and 328100 over the past ten days. A total of 59.92M shares are outstanding, with a floating share count of 53.74M. Insiders hold about 11.68% of the company’s shares, while institutions hold 97.70% stake in the company. Shares short for PLRX as of 1730332800 were 7215830 with a Short Ratio of 19.70, compared to 1727654400 on 6767543. Therefore, it implies a Short% of Shares Outstanding of 7215830 and a Short% of Float of 12.109999.
